BioVie Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Selling, General & Admin	11.55	9.77	4.64	1.31	1.26	1.77	0.07	0.02	0.02	0.03
Research & Development	33.3	17.26	133.19	1.15	1.01	0.37	0.47	0.04	0	0.05
Other Operating Expenses	0.23	0.23	0.23	0.23	0.23	0.23	1.02	0.38	0.21	0.25
Operating Expenses	45.08	27.25	138.05	2.69	2.5	2.37	1.55	0.43	0.23	0.32
Operating Income	-45.08	-27.25	-138.05	-2.69	-2.5	-2.37	-1.55	-0.43	-0.23	-0.32
Interest Expense / Income	4.3	2.16	0.56	4.77	0	0.04	0	0	0	0
Other Expense / Income	0.88	-3.33	-8.36	9.21	-0.05	-0	-0.22	-0	-0	-0
Pretax Income	-50.26	-26.08	-130.25	-16.68	-2.44	-2.41	-1.33	-0.43	-0.23	-0.32
Net Income	-50.26	-26.08	-130.25	-16.68	-2.44	-2.41	-1.33	-0.43	-0.23	-0.32
Preferred Dividends	0	0	53.6	17.1	0.05	0.02	0	0	0	0
Net Income Common	-50.26	-26.08	-183.85	-33.78	-2.49	-2.43	-1.33	-0.43	-0.23	-0.32
Shares Outstanding (Basic)	32	25	12	5	3	1	1	1	1	1
Shares Outstanding (Diluted)	32	25	12	5	3	1	1	1	1	1
Shares Change	31.71%	98.84%	151.61%	94.10%	231.51%	7.12%	2.51%	-0.01%	0.15%	-
EPS (Basic)	-1.55	-1.06	-14.82	-6.85	-0.98	-3.75	-1.25	-	-	-
EPS (Diluted)	-1.55	-1.06	-14.82	-6.85	-0.98	-3.75	-1.25	-	-	-
Free Cash Flow	-40.25	-18.99	-10.45	-1.63	-2.5	-0.62	-0.62	-0.15	-0.07	-0.17
Free Cash Flow Per Share	-1.24	-0.77	-0.84	-0.33	-0.98	-0.81	-0.87	-0.22	-0.09	-0.25
EBITDA	-45.73	-23.69	-129.46	-11.67	-2.21	-2.14	-1.1	-0.38	-0.23	-0.32
Depreciation & Amortization	0.23	0.23	0.23	0.23	0.23	0.23	0.23	0.05	0	0
EBIT	-45.96	-23.92	-129.69	-11.9	-2.44	-2.37	-1.33	-0.43	-0.23	-0.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).